The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
Authors:
- Dov WexlerDWDov Wexler
- David ShepsDSDavid Sheps
- Miriam BlumMBMiriam Blum
- Gad KerenGKGad Keren
- Ron BaruchRBRon Baruch
- Doron SchwartzDSDoron Schwartz
- Tatyana YachninTYTatyana Yachnin
- Shoshana SteinbruchSSShoshana Steinbruch
- Itzhak ShapiraISItzhak Shapira
- Shlomo LaniadoSLShlomo Laniado
- Adrian IainaAIAdrian Iaina
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Mesangiolytic glomerulopathy in severe congestive heart failureKidney International, 1998
- Effect of anaemia and cardiovascular disease on surgical mortality and morbidityThe Lancet, 1996
- Concomitant Factors of Decompensation in Chronic Heart FailureThe American Journal of Cardiology, 1996
- Intravenous Ferric Saccharate as an Iron Supplement in Dialysis PatientsNephron, 1996
- Early Predictors of 15-Year End-Stage Renal Disease in Hypertensive PatientsHypertension, 1995
- Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factorsKidney International, 1995
- Erythropoietin Modified the Cardiac Action of Ouabain in Chronically Anaemic-Uraemic RatsNephron, 1995
- Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietinAmerican Heart Journal, 1992
- Therapy with Recombinant Human Erythropoietin Reduces Cardiac Size and Improves Heart Function in Chronic Hemodialysis PatientsAmerican Journal of Nephrology, 1991
- Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: Validation of the technique and assessment of variabilityThe American Journal of Cardiology, 1979